Literature DB >> 19442195

Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine.

Selim Kuçi1, Zyrafete Kuçi, Hatixhe Latifi-Pupovci, Dietrich Niethammer, Rupert Handgretinger, Michael Schumm, Gernot Bruchelt, Peter Bader, Thomas Klingebiel.   

Abstract

Embryonic stem cells are by definition the master cells capable of differentiating into every type of cells either in vitro or in vivo. Several lines of evidence suggest, however, that adult stem cells and even terminally differentiated somatic cells under appropriate microenvironmental cues are able to be reprogrammed and contribute to a much wider spectrum of differentiated progeny than previously anticipated. This has been demonstrated by using tissue- specific stem cells, which like embryonic stem cells do not express CD45 as an exclusive hematopoietic marker (skin, adipose, cord blood and bone marrow- derived stem cells). On the other side, there is a great number of reports which demonstrate that hematopoietic cells (CD45+) from different sources (peripheral blood, cord blood, bone marrow) are also able to cross the tissue boundaries and give rise to the cells of the other germ layers. Herein we discuss the differentiation and reprogramming potential of both hematopoietic and non- hematopoietic stem cells along endodermal, mesodermal and neuroectodermal lineage and their importance for regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442195     DOI: 10.2174/157488809788167427

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  14 in total

1.  Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products.

Authors:  Giuseppe Astori; Sabrina Soncin; Viviana Lo Cicero; Francesco Siclari; Daniel Sürder; Lucia Turchetto; Gianni Soldati; Tiziano Moccetti
Journal:  Am J Transl Res       Date:  2010-05-15       Impact factor: 4.060

2.  Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery.

Authors:  Peter V Hauser; Roberta De Fazio; Stefania Bruno; Simona Sdei; Cristina Grange; Benedetta Bussolati; Chiara Benedetto; Giovanni Camussi
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  The histone methyltransferase inhibitor BIX01294 enhances the cardiac potential of bone marrow cells.

Authors:  Nadejda V Mezentseva; Jinpu Yang; Keerat Kaur; Grazia Iaffaldano; Mathieu C Rémond; Carol A Eisenberg; Leonard M Eisenberg
Journal:  Stem Cells Dev       Date:  2012-11-07       Impact factor: 3.272

Review 4.  Role of mesenchymal stem cell-derived microvesicles in tissue repair.

Authors:  Stefania Bruno; Giovanni Camussi
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

Review 5.  Stem cell therapy for retinal diseases: update.

Authors:  Rubens Camargo Siqueira
Journal:  Stem Cell Res Ther       Date:  2011-12-29       Impact factor: 6.832

Review 6.  CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

7.  Comparison of phenotypic markers and neural differentiation potential of multipotent adult progenitor cells and mesenchymal stem cells.

Authors:  Saurabh Pratap Singh; Naresh Kumar Tripathy; Soniya Nityanand
Journal:  World J Stem Cells       Date:  2013-04-26       Impact factor: 5.326

8.  Sorting single satellite cells from individual myofibers reveals heterogeneity in cell-surface markers and myogenic capacity.

Authors:  Matthew R Chapman; Karthik R Balakrishnan; Ju Li; Michael J Conboy; Haiyan Huang; Swomitra K Mohanty; Eric Jabart; James Hack; Irina M Conboy; Lydia L Sohn
Journal:  Integr Biol (Camb)       Date:  2013-02-13       Impact factor: 2.192

9.  MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral Blood.

Authors:  Paul J Mintz; Pål Sætrom; Vikash Reebye; Marie B Lundbæk; Kaiqin Lao; John J Rossi; Karin Ml Gaensler; Noriyuki Kasahara; Joanna P Nicholls; Steen Jensen; Abdelali Haoudi; Mohamed M Emara; Myrtle Ya Gordon; Nagy A Habib
Journal:  Mol Ther Nucleic Acids       Date:  2012-08-07       Impact factor: 10.183

10.  Promotion of the toxic action of cyclophosphamide by digestive tract luminal ammonia in rats.

Authors:  Jury Ju Ivnitsky; Timur V Schäfer; Vladimir L Rejniuk
Journal:  ISRN Toxicol       Date:  2011-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.